Tags : Small Molecule

Pharma

Roche Signs a License Agreement with Arrakis Therapeutics for the

Shots: Arrakis to receive $190M up front in cash and is eligible to get several billion dollars in pre/clinical and commercial milestones along with royalties for products emerging from the collaboration Arrakis will be responsible for discovery and research activities of each target to a defined point while Roche will get right to exclusively pursue […]Read More